Japan drugmakers aim for biopharma surge with expanded talent pool
TOKYO -- Japanese pharmaceutical companies including Daiichi Sankyo and Fujifilm Holdings are increasing efforts to develop biopharmaceutical talent, aiming for 50% to 100% growth in such experts as they seek to catch up with overseas rivals. These …